Risultati della ricerca - Nadja Fratzl‐Zelman
- Mostra 1 - 13 risultati su 13
-
1
Mineralization density distribution of postmenopausal osteoporotic bone is restored to normal after long-term alendronate treatment: qBEI and sSAXS data from the fracture intervent... di Paul Roschger, Assunta Lombardi, Barbara M. Misof, G. Maier, Nadja Fratzl‐Zelman, Peter Fratzl, K. Klaushofer
Pubblicazione 2009Artigo -
2
-
3
-
4
-
5
Combination of Nanoindentation and Quantitative Backscattered Electron Imaging Revealed Altered Bone Material Properties Associated with Femoral Neck Fragility di Nadja Fratzl‐Zelman, Paul Roschger, Aurélien Gourrier, Markus Weber, Barbara M. Misof, N. Loveridge, J. Reeve, K. Klaushofer, Peter Fratzl
Pubblicazione 2009Artigo -
6
Cardiac, bone and growth plate manifestations in hypocalcemic infants: revealing the hidden body of the vitamin D deficiency iceberg di Suma Uday, Nadja Fratzl‐Zelman, Paul Roschger, Klaus Klaushofer, Ashish Chikermane, Vrinda Saraff, T H Tulchinsky, Tom D. Thacher, Tamás Marton, Wolfgang Högler
Pubblicazione 2018Artigo -
7
Reversible Deterioration in Hypophosphatasia Caused by Renal Failure With Bisphosphonate Treatment di Tim Cundy, Toshimi Michigami, Kanako Tachikawa, Michael Dray, John Collins, Eleftherios P. Paschalis, Sonja Gamsjaeger, Andreas Roschger, Nadja Fratzl‐Zelman, Paul Roschger, Klaus Klaushofer
Pubblicazione 2015Artigo -
8
Evidence for a Role for Nanoporosity and Pyridinoline Content in Human Mild Osteogenesis Imperfecta di Eleftherios P. Paschalis, Sonja Gamsjaeger, Nadja Fratzl‐Zelman, Paul Roschger, Admir Mašić, Wolfgang Brozek, N. Hassler, Francis H. Glorieux, Frank Rauch, Klaus Klaushofer, Peter Fratzl
Pubblicazione 2016Artigo -
9
A neomorphic variant in SP7 alters sequence specificity and causes a high-turnover bone disorder di Julian C. Lui, Adalbert Raimann, Hironori Hojo, Lijin Dong, Paul Roschger, Bijal Kikani, Uwe Wintergerst, Nadja Fratzl‐Zelman, Youn Hee Jee, G. Haeusler, Jeffrey Baron
Pubblicazione 2022Artigo -
10
Bone material quality in transiliac bone biopsies of postmenopausal osteoporotic women after 3 years of strontium ranelate treatment di Paul Roschger, I. Manjubala, N. Zoeger, Florian Meirer, Rolf Simon, Chenghao Li, Nadja Fratzl‐Zelman, Barbara M. Misof, Eleftherios P. Paschalis, Christina Streli, Peter Fratzl, Klaus Klaushofer
Pubblicazione 2009Artigo -
11
Somatic activating mutations in MAP2K1 cause melorheostosis di Heeseog Kang, Smita Jha, Zuoming Deng, Nadja Fratzl‐Zelman, Wayne A. Cabral, Aleksandra Ivovic, Françoise Meylan, Eric P. Hanson, Eileen Lange, James D. Katz, Paul Roschger, Klaus Klaushofer, Edward W. Cowen, Richard M. Siegel, Joan C. Marini, Timothy Bhattacharyya
Pubblicazione 2018Artigo -
12
Somatic <i>SMAD3</i>-activating mutations cause melorheostosis by up-regulating the TGF-β/SMAD pathway di Heeseog Kang, Smita Jha, Aleksandra Ivovic, Nadja Fratzl‐Zelman, Zuoming Deng, Apratim Mitra, Wayne A. Cabral, Eric P. Hanson, Eileen Lange, Edward W. Cowen, James D. Katz, Paul Roschger, Klaus Klaushofer, Ryan Dale, Richard M. Siegel, Timothy Bhattacharyya, Joan C. Marini
Pubblicazione 2020Artigo -
13
COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta di Katarina Lindahl, Aileen M. Barnes, Nadja Fratzl‐Zelman, Michael P. Whyte, Theresa E. Hefferan, Elena Makareeva, Marina Brusel, Michael J. Yaszemski, Carl‐Johan Rubin, Andreas Kindmark, Paul Roschger, Klaus Klaushofer, William H. McAlister, Steven Mumm, Sergey Leikin, Efrat Kessler, Adele L. Boskey, Östen Ljunggren, Joan C. Marini
Pubblicazione 2011Artigo
Strumenti per la ricerca:
Soggetti correlati
Medicine
Internal medicine
Chemistry
Osteoporosis
Endocrinology
Anatomy
Biology
Gene
Genetics
In vitro
Osteoblast
Osteogenesis imperfecta
Type I collagen
Biochemistry
Bone mineral
Bone remodeling
Dentistry
Mineralization (soil science)
Mutation
Pathology
Alkaline phosphatase
Bone density
Cancellous bone
Cancer research
Cell biology
Composite material
Dentinogenesis imperfecta
Enzyme
Materials science
Mathematics